Regenxbio Inc (RGNX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.75
• Market Cap: $431.81M
• EPS: $-3.46
• 52-Week High: $16.19
• 52-Week Low: $5.04

Market Sentiment

Regenxbio Inc currently has a Bearish sentiment score of -0.49.

About Regenxbio Inc

Regenxbio Inc. is a clinical-stage biotechnology company focused on advancing gene therapies for a range of genetic disorders. Utilizing its proprietary AAV9 gene delivery platform, the company develops innovative treatments designed to address genetic defects by enabling cells to produce therapeutic proteins or antibodies that target disease. Headquartered in Rockville, Maryland, Regenxbio is committed to transforming the lives of patients with serious conditions through cutting-edge gene th...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Regenxbio Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RGNX pay dividends?

Regenxbio Inc (RGNX) does not currently pay a regular dividend.

What is RGNX's market cap?

Regenxbio Inc (RGNX) has a market capitalization of $431.81M with a current stock price of $8.75.